What type of adjudication was used to assess endpoints and by what criteria?
Clinical events identified as possibly constituting a primary or secondary study endpoint were passed through a central adjudication process, which was blinded regarding study treatment allocation. For example, as they were not part of the primary or secondary endpoints, but classified as adverse events, heart failure events were reported by the local investigators and not centrally adjudicated. No information on the criteria used was provided.
